Cargando…

Oxytocin as an adolescent treatment for methamphetamine addiction after early life stress in male and female rats

Early life stress (ELS) is associated with perturbed neural development and augmented vulnerability to mental health disorders, including addiction. How ELS changes the brain to increase addiction risk is poorly understood, and there are no therapies which target this ELS-induced vulnerability. ELS...

Descripción completa

Detalles Bibliográficos
Autores principales: Baracz, Sarah J., Robinson, Katherine J., Wright, Amanda L., Turner, Anita J., McGregor, Iain S., Cornish, Jennifer L., Everett, Nicholas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206013/
https://www.ncbi.nlm.nih.gov/pubmed/35581382
http://dx.doi.org/10.1038/s41386-022-01336-y
_version_ 1784729252038443008
author Baracz, Sarah J.
Robinson, Katherine J.
Wright, Amanda L.
Turner, Anita J.
McGregor, Iain S.
Cornish, Jennifer L.
Everett, Nicholas A.
author_facet Baracz, Sarah J.
Robinson, Katherine J.
Wright, Amanda L.
Turner, Anita J.
McGregor, Iain S.
Cornish, Jennifer L.
Everett, Nicholas A.
author_sort Baracz, Sarah J.
collection PubMed
description Early life stress (ELS) is associated with perturbed neural development and augmented vulnerability to mental health disorders, including addiction. How ELS changes the brain to increase addiction risk is poorly understood, and there are no therapies which target this ELS-induced vulnerability. ELS disrupts the oxytocin system, which can modulate addiction susceptibility, suggesting that targeting the oxytocin system may be therapeutic in this ELS-addiction comorbidity. Therefore, we determined whether adolescent oxytocin treatment after ELS could: (1) reduce vulnerability to anxiety, social deficits, and methamphetamine-taking and reinstatement; and (2) restore hypothalamic oxytocin and corticotropin-releasing factor expressing neurons and peripheral oxytocin and corticosterone levels. Long Evans pups underwent maternal separation (MS) for either 15 min or 360 min on postnatal days (PND) 1–21. During adolescence (PNDs 28–42), rats received a daily injection of either oxytocin or saline. In Experiment 1, adult rats were assessed using the elevated plus-maze, social interaction procedure, and methamphetamine self-administration procedure, including extinction, and cue-, methamphetamine- and yohimbine-induced reinstatement. In Experiment 2, plasma for enzyme immunoassays and brain tissue for immunofluorescence were collected from adult rats after acute stress exposure. Adolescent oxytocin treatment ameliorated ELS-induced anxiety and reduced methamphetamine- and yohimbine-induced reinstatement in both sexes, and suppressed methamphetamine intake and facilitated extinction in males only. Additionally, adolescent oxytocin treatment after ELS restored oxytocin-immunoreactive cells and stress-induced oxytocin levels in males, and attenuated stress-induced corticosterone levels in both sexes. Adolescent oxytocin treatment reverses some of the ELS effects on later-life psychopathology and vulnerability to addiction.
format Online
Article
Text
id pubmed-9206013
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-92060132022-06-19 Oxytocin as an adolescent treatment for methamphetamine addiction after early life stress in male and female rats Baracz, Sarah J. Robinson, Katherine J. Wright, Amanda L. Turner, Anita J. McGregor, Iain S. Cornish, Jennifer L. Everett, Nicholas A. Neuropsychopharmacology Article Early life stress (ELS) is associated with perturbed neural development and augmented vulnerability to mental health disorders, including addiction. How ELS changes the brain to increase addiction risk is poorly understood, and there are no therapies which target this ELS-induced vulnerability. ELS disrupts the oxytocin system, which can modulate addiction susceptibility, suggesting that targeting the oxytocin system may be therapeutic in this ELS-addiction comorbidity. Therefore, we determined whether adolescent oxytocin treatment after ELS could: (1) reduce vulnerability to anxiety, social deficits, and methamphetamine-taking and reinstatement; and (2) restore hypothalamic oxytocin and corticotropin-releasing factor expressing neurons and peripheral oxytocin and corticosterone levels. Long Evans pups underwent maternal separation (MS) for either 15 min or 360 min on postnatal days (PND) 1–21. During adolescence (PNDs 28–42), rats received a daily injection of either oxytocin or saline. In Experiment 1, adult rats were assessed using the elevated plus-maze, social interaction procedure, and methamphetamine self-administration procedure, including extinction, and cue-, methamphetamine- and yohimbine-induced reinstatement. In Experiment 2, plasma for enzyme immunoassays and brain tissue for immunofluorescence were collected from adult rats after acute stress exposure. Adolescent oxytocin treatment ameliorated ELS-induced anxiety and reduced methamphetamine- and yohimbine-induced reinstatement in both sexes, and suppressed methamphetamine intake and facilitated extinction in males only. Additionally, adolescent oxytocin treatment after ELS restored oxytocin-immunoreactive cells and stress-induced oxytocin levels in males, and attenuated stress-induced corticosterone levels in both sexes. Adolescent oxytocin treatment reverses some of the ELS effects on later-life psychopathology and vulnerability to addiction. Springer International Publishing 2022-05-17 2022-07 /pmc/articles/PMC9206013/ /pubmed/35581382 http://dx.doi.org/10.1038/s41386-022-01336-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Baracz, Sarah J.
Robinson, Katherine J.
Wright, Amanda L.
Turner, Anita J.
McGregor, Iain S.
Cornish, Jennifer L.
Everett, Nicholas A.
Oxytocin as an adolescent treatment for methamphetamine addiction after early life stress in male and female rats
title Oxytocin as an adolescent treatment for methamphetamine addiction after early life stress in male and female rats
title_full Oxytocin as an adolescent treatment for methamphetamine addiction after early life stress in male and female rats
title_fullStr Oxytocin as an adolescent treatment for methamphetamine addiction after early life stress in male and female rats
title_full_unstemmed Oxytocin as an adolescent treatment for methamphetamine addiction after early life stress in male and female rats
title_short Oxytocin as an adolescent treatment for methamphetamine addiction after early life stress in male and female rats
title_sort oxytocin as an adolescent treatment for methamphetamine addiction after early life stress in male and female rats
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206013/
https://www.ncbi.nlm.nih.gov/pubmed/35581382
http://dx.doi.org/10.1038/s41386-022-01336-y
work_keys_str_mv AT baraczsarahj oxytocinasanadolescenttreatmentformethamphetamineaddictionafterearlylifestressinmaleandfemalerats
AT robinsonkatherinej oxytocinasanadolescenttreatmentformethamphetamineaddictionafterearlylifestressinmaleandfemalerats
AT wrightamandal oxytocinasanadolescenttreatmentformethamphetamineaddictionafterearlylifestressinmaleandfemalerats
AT turneranitaj oxytocinasanadolescenttreatmentformethamphetamineaddictionafterearlylifestressinmaleandfemalerats
AT mcgregoriains oxytocinasanadolescenttreatmentformethamphetamineaddictionafterearlylifestressinmaleandfemalerats
AT cornishjenniferl oxytocinasanadolescenttreatmentformethamphetamineaddictionafterearlylifestressinmaleandfemalerats
AT everettnicholasa oxytocinasanadolescenttreatmentformethamphetamineaddictionafterearlylifestressinmaleandfemalerats